Olivia Hurtado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Olivia Hurtado has a total of 156 co-authors. Here are the top co-authors by number of shared publications:
- Maria Angeles Moro
Cardiovascular Risk Factors and Brain Function Programme, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
45 shared publications - Ignacio Lizasoain
Instituto de Investigación Hospital 12 Octubre (imas12), Spain
43 shared publications - Juan Carlos Leza
Department of Pharmacology and Toxicology, Faculty of Medicine, University Complutense Madrid (UCM); Research Institute of Hospital 12 de Octubre (Imas12); University Institute of Research in Neurochemistry of the UCM (IUIN-UCM), Madrid, Spain
17 shared publications - Jesus Miguel Pradillo
Pharmacology and Toxicology Department and University Research Institute of Neurochemistry, School of Medicine University Complutense of Madrid Madrid Spain
16 shared publications Pedro Lorenzo
Departamento de Farmacología, Facultad de Medicina, Universidad Complutense de Madrid (UCM), Madrid, Spain
16 shared publications- José Castillo
Neuroimaging and Biotechnology Laboratory (NOBEL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain
12 shared publications
Latest Publications
- Open Access
Does Infarct Size Influence Gut Barrier Integrity and Bacterial Translocation after Experimental Stroke?
Background: Ischemic stroke (IS) triggers brain injury and systemic changes, including gut dysbiosis, intestinal barrier dysfunction (IBD), and bacterial translocation (BT). Although larger infarcts are associated with higher infection risk, it is unclear whether lesion size directly influences gut barrier integrity or bacterial dissemination. Methods: Male C57BL/6 mice underwent permanent middle cerebral artery occlusion (MCAO) proximally or distally to generate large or small infarcts. Seventy-two hours post-ischemia, infarct volume was measured by MRI, and BT was assessed in mesenteric lymph nodes, liver, spleen, and lungs. ZO-1 and MMP9 expression were used to evaluate intestinal barrier integrity. Peripheral and central inflammation were assessed by flow cytometry and immunofluorescence. Results: Proximal MCAO produced larger infarcts than distal MCAO. The proportion of animals exhibiting BT was lower in distal MCAO, but this difference was not statistically significant. ZO-1 expression did not differ between groups, while MMP9 was increased only in animals with BT, independent of infarct size. BT was associated with more pronounced lymphopenia and enhanced microglial activation and T-cell infiltration in the brain. The composition of translocated bacteria was similar across groups. Conclusions: Infarct size alone does not determine IBD or BT, although BT is linked to intestinal and cerebral inflammation. This study evaluates for the first time the effect of lesion magnitude on IBD and BT, highlighting the complex interplay between cerebral injury and gut–systemic interactions.
Open AccessDoes Infarct Size Influence Gut Barrier Integrity and Bacterial Translocation after Experimental Stroke?
Background: Ischemic stroke (IS) triggers brain injury and systemic changes, including gut dysbiosis, intestinal barrier dysfunction (IBD), and bacterial translocation (BT). Although larger infarcts are associated with higher infection risk, it is unclear whether lesion size directly influences gut barrier integrity or bacterial dissemination. Methods: Male C57BL/6 mice underwent permanent middle cerebral artery occlusion (MCAO) proximally or distally to generate large or small infarcts. Seventy-two hours post-ischemia, infarct volume was measured by MRI, and BT was assessed in mesenteric lymph nodes, liver, spleen, and lungs. ZO-1 and MMP9 expression were used to evaluate intestinal barrier integrity. Peripheral and central inflammation were assessed by flow cytometry and immunofluorescence. Results: Proximal MCAO produced larger infarcts than distal MCAO. The proportion of animals exhibiting BT was lower in distal MCAO, but this difference was not statistically significant. ZO-1 expression did not differ between groups, while MMP9 was increased only in animals with BT, independent of infarct size. BT was associated with more pronounced lymphopenia and enhanced microglial activation and T-cell infiltration in the brain. The composition of translocated bacteria was similar across groups. Conclusions: Infarct size alone does not determine IBD or BT, although BT is linked to intestinal and cerebral inflammation. This study evaluates for the first time the effect of lesion magnitude on IBD and BT, highlighting the complex interplay between cerebral injury and gut–systemic interactions.
- Open Access
Sub-strain-Dependent Differences in Gut Barrier Permeability, Bacterial Translocation and Post-Stroke Inflammation in Wistar Rats
Background: Stroke induces profound neuroinflammation and systemic immune dysregulation, including disturbances in gut homeostasis. Experimental evidence suggests that intestinal barrier permeability (IBP) and bacterial translocation (BT) critically influence stroke outcomes. However, biological variability among commonly used rodent sub-strains has received limited attention. Methods: In this pilot study, we compared post-stroke immune responses in two Wistar rat sub-strains obtained from different suppliers: RccHan (Envigo) and RjHan (Janvier). Following transient middle cerebral artery occlusion, animals were assessed 72 hours later and stratified according to the presence or absence of BT. Immune cell populations in blood and bone marrow were analyzed by flow cytometry, and leukocyte infiltration into ischemic brain tissue was quantified by immunohistochemistry. Results: Both sub-strains developed significant infarcts and neurological deficits. RccHan rats displayed larger infarct volumes and more extensive BT across multiple organs. In contrast, RjHan rats exhibited BT mainly confined to mesenteric lymph nodes but showed greater IBP. Although dissemination was broader in RccHan rats, overall bacterial burden was slightly lower compared with RjHan, and extra-intestinal bacterial composition differed between groups. Notably, RjHan rats presented stronger systemic and central immune activation, with marked alterations in lymphocyte and monocyte populations and enhanced granulocyte and T cell infiltration within ischemic lesions. Conclusions: These findings demonstrate that sub-strain origin profoundly influences post-stroke intestinal barrier integrity, bacterial dissemination, and immune responses. Considering sub-strain-related variability is essential to improve reproducibility and translational relevance in preclinical stroke research.
Open AccessSub-strain-Dependent Differences in Gut Barrier Permeability, Bacterial Translocation and Post-Stroke Inflammation in Wistar Rats
Background: Stroke induces profound neuroinflammation and systemic immune dysregulation, including disturbances in gut homeostasis. Experimental evidence suggests that intestinal barrier permeability (IBP) and bacterial translocation (BT) critically influence stroke outcomes. However, biological variability among commonly used rodent sub-strains has received limited attention. Methods: In this pilot study, we compared post-stroke immune responses in two Wistar rat sub-strains obtained from different suppliers: RccHan (Envigo) and RjHan (Janvier). Following transient middle cerebral artery occlusion, animals were assessed 72 hours later and stratified according to the presence or absence of BT. Immune cell populations in blood and bone marrow were analyzed by flow cytometry, and leukocyte infiltration into ischemic brain tissue was quantified by immunohistochemistry. Results: Both sub-strains developed significant infarcts and neurological deficits. RccHan rats displayed larger infarct volumes and more extensive BT across multiple organs. In contrast, RjHan rats exhibited BT mainly confined to mesenteric lymph nodes but showed greater IBP. Although dissemination was broader in RccHan rats, overall bacterial burden was slightly lower compared with RjHan, and extra-intestinal bacterial composition differed between groups. Notably, RjHan rats presented stronger systemic and central immune activation, with marked alterations in lymphocyte and monocyte populations and enhanced granulocyte and T cell infiltration within ischemic lesions. Conclusions: These findings demonstrate that sub-strain origin profoundly influences post-stroke intestinal barrier integrity, bacterial dissemination, and immune responses. Considering sub-strain-related variability is essential to improve reproducibility and translational relevance in preclinical stroke research.
- 1 October 2023
- Published by Wolters Kluwer Health in Stroke
- Vol. 54 (10) , 2652-2665
Ipsilesional Hippocampal GABA Is Elevated and Correlates With Cognitive Impairment and Maladaptive Neurogenesis After Cortical Stroke in Mice
BACKGROUND: Cognitive dysfunction is a frequent stroke sequela, but its pathogenesis and treatment remain unresolved. Involvement of aberrant hippocampal neurogenesis and maladaptive circuitry remodeling has been proposed, but their mechanisms are unknown. Our aim was to evaluate potential underlying molecular/cellular events implicated. METHODS: Stroke was induced by permanent occlusion of the middle cerebral artery occlusion in 2-month-old C57BL/6 male mice. Hippocampal metabolites/neurotransmitters were analyzed longitudinally by in vivo magnetic resonance spectroscopy. Cognitive function was evaluated with the contextual fear conditioning test. Microglia, astrocytes, neuroblasts, interneurons, γ-aminobutyric acid (GABA), and c-fos were analyzed by immunofluorescence. RESULTS: Approximately 50% of mice exhibited progressive post–middle cerebral artery occlusion cognitive impairment. Notably, immature hippocampal neurons in the impaired group displayed more severe aberrant phenotypes than those from the nonimpaired group. Using magnetic resonance spectroscopy, significant bilateral changes in hippocampal metabolites, such as myo-inositol or N-acetylaspartic acid, were found that correlated, respectively, with numbers of glia and immature neuroblasts in the ischemic group. Importantly, some metabolites were specifically altered in the ipsilateral hippocampus suggesting its involvement in aberrant hippocampal neurogenesis and remodeling processes. Specifically, middle cerebral artery occlusion animals with higher hippocampal GABA levels displayed worse cognitive outcome. Implication of GABA in this setting was supported by the amelioration of ischemia-induced memory deficits and aberrant hippocampal neurogenesis after blocking pharmacologically GABAergic neurotransmission, an intervention which was ineffective when neurogenesis was inhibited. These data suggest that GABA exerts its detrimental effect, at least partly, by affecting morphology and integration of newborn neurons into the hippocampal circuits. CONCLUSIONS: Hippocampal GABAergic neurotransmission could be considered a novel diagnostic and therapeutic target for poststroke cognitive impairment.
- 1 October 2023
- Published by Wolters Kluwer Health in Stroke
- Vol. 54 (10) , 2652-2665
Ipsilesional Hippocampal GABA Is Elevated and Correlates With Cognitive Impairment and Maladaptive Neurogenesis After Cortical Stroke in Mice
BACKGROUND: Cognitive dysfunction is a frequent stroke sequela, but its pathogenesis and treatment remain unresolved. Involvement of aberrant hippocampal neurogenesis and maladaptive circuitry remodeling has been proposed, but their mechanisms are unknown. Our aim was to evaluate potential underlying molecular/cellular events implicated. METHODS: Stroke was induced by permanent occlusion of the middle cerebral artery occlusion in 2-month-old C57BL/6 male mice. Hippocampal metabolites/neurotransmitters were analyzed longitudinally by in vivo magnetic resonance spectroscopy. Cognitive function was evaluated with the contextual fear conditioning test. Microglia, astrocytes, neuroblasts, interneurons, γ-aminobutyric acid (GABA), and c-fos were analyzed by immunofluorescence. RESULTS: Approximately 50% of mice exhibited progressive post–middle cerebral artery occlusion cognitive impairment. Notably, immature hippocampal neurons in the impaired group displayed more severe aberrant phenotypes than those from the nonimpaired group. Using magnetic resonance spectroscopy, significant bilateral changes in hippocampal metabolites, such as myo-inositol or N-acetylaspartic acid, were found that correlated, respectively, with numbers of glia and immature neuroblasts in the ischemic group. Importantly, some metabolites were specifically altered in the ipsilateral hippocampus suggesting its involvement in aberrant hippocampal neurogenesis and remodeling processes. Specifically, middle cerebral artery occlusion animals with higher hippocampal GABA levels displayed worse cognitive outcome. Implication of GABA in this setting was supported by the amelioration of ischemia-induced memory deficits and aberrant hippocampal neurogenesis after blocking pharmacologically GABAergic neurotransmission, an intervention which was ineffective when neurogenesis was inhibited. These data suggest that GABA exerts its detrimental effect, at least partly, by affecting morphology and integration of newborn neurons into the hippocampal circuits. CONCLUSIONS: Hippocampal GABAergic neurotransmission could be considered a novel diagnostic and therapeutic target for poststroke cognitive impairment.
- Open Access
- 16 March 2023
- Published by Elsevier in Food and Bioproducts Processing
- Vol. 139, 89-97
Enzymatic production of sustainable jojoba fatty alcohols: A Biorefinery approach
- 16 March 2023
- Published by Elsevier in Food and Bioproducts Processing
- Vol. 139, 89-97
Open AccessEnzymatic production of sustainable jojoba fatty alcohols: A Biorefinery approach
- 1 August 2019
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 80, 573-582
Toll-like receptor 4 regulates subventricular zone proliferation and neuroblast migration after experimental stroke
- 1 August 2019
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 80, 573-582
Toll-like receptor 4 regulates subventricular zone proliferation and neuroblast migration after experimental stroke
- Open Access
- 27 November 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-12
Specific Features of SVZ Neurogenesis After Cortical Ischemia: a Longitudinal Study
Stroke is a devastating disease with an increasing prevalence. Part of the current development in stroke therapy is focused in the chronic phase, where neurorepair mechanisms such as neurogenesis, are involved. In the adult brain, one of the regions where neurogenesis takes place is the subventricular zone (SVZ) of the lateral ventricles. Given the possibility to develop pharmacological therapies to stimulate this process, we have performed a longitudinal analysis of neurogenesis in a model of cortical ischemia in mice. Our results show an initial decrease of SVZ proliferation at 24 h, followed by a recovery leading to an increase at 14d and a second decrease 28d after stroke. Coinciding with the 24 h proliferation decrease, an increase in the eutopic neuroblast migration towards the olfactory bulb was observed. The analysis of the neuroblast ectopic migration from the SVZ toward the lesion showed an increase in this process from day 14 after the insult. Finally, our data revealed an increased number of new cortical neurons in the peri-infarct cortex 65d after the insult. In summary, we report here critical check-points about post-stroke neurogenesis after cortical infarcts, important for the pharmacological modulation of this process in stroke patients.
- 27 November 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-12
Open AccessSpecific Features of SVZ Neurogenesis After Cortical Ischemia: a Longitudinal Study
Stroke is a devastating disease with an increasing prevalence. Part of the current development in stroke therapy is focused in the chronic phase, where neurorepair mechanisms such as neurogenesis, are involved. In the adult brain, one of the regions where neurogenesis takes place is the subventricular zone (SVZ) of the lateral ventricles. Given the possibility to develop pharmacological therapies to stimulate this process, we have performed a longitudinal analysis of neurogenesis in a model of cortical ischemia in mice. Our results show an initial decrease of SVZ proliferation at 24 h, followed by a recovery leading to an increase at 14d and a second decrease 28d after stroke. Coinciding with the 24 h proliferation decrease, an increase in the eutopic neuroblast migration towards the olfactory bulb was observed. The analysis of the neuroblast ectopic migration from the SVZ toward the lesion showed an increase in this process from day 14 after the insult. Finally, our data revealed an increased number of new cortical neurons in the peri-infarct cortex 65d after the insult. In summary, we report here critical check-points about post-stroke neurogenesis after cortical infarcts, important for the pharmacological modulation of this process in stroke patients.
- 1 January 2017
- Published by Wolters Kluwer Health in Stroke
- Vol. 48 (1) , 204-212
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke
Background and Purpose—: Stroke is a leading cause of adult disability characterized by physical, cognitive, and emotional disturbances. Unfortunately, pharmacological options are scarce. The cannabinoid type-2 receptor (CB2R) is neuroprotective in acute experimental stroke by anti-inflammatory mechanisms. However, its role in chronic stroke is still unknown. Methods—: Stroke was induced by permanent middle cerebral artery occlusion in mice; CB2R modulation was assessed by administering the CB2R agonist JWH133 ((6aR,10aR)-3-(1,1-dimethylbutyl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran) or the CB2R antagonist SR144528 ( N -[(1S)- endo -1,3,3-trimethylbicyclo-[2.2.1]-heptan-2-yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide) once daily from day 3 to the end of the experiment or by CB2R genetic deletion. Analysis of immunofluorescence-labeled brain sections, 5-bromo-2´-deoxyuridine (BrdU) staining, fluorescence-activated cell sorter analysis of brain cell suspensions, and behavioral tests were performed. Results—: SR144528 decreased neuroblast migration toward the boundary of the infarct area when compared with vehicle-treated mice 14 days after middle cerebral artery occlusion. Consistently, mice on this pharmacological treatment, like mice with CB2R genetic deletion, displayed a lower number of new neurons (NeuN + /BrdU + cells) in peri-infarct cortex 28 days after stroke when compared with vehicle-treated group, an effect accompanied by a worse sensorimotor performance in behavioral tests. The CB2R agonist did not affect neurogenesis or outcome in vivo, but increased the migration of neural progenitor cells in vitro; the CB2R antagonist alone did not affect in vitro migration. Conclusions—: Our data support that CB2R is fundamental for driving neuroblast migration and suggest that an endocannabinoid tone is required for poststroke neurogenesis by promoting neuroblast migration toward the injured brain tissue, increasing the number of new cortical neurons and, conceivably, enhancing motor functional recovery after stroke.
- 1 January 2017
- Published by Wolters Kluwer Health in Stroke
- Vol. 48 (1) , 204-212
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke
Background and Purpose—: Stroke is a leading cause of adult disability characterized by physical, cognitive, and emotional disturbances. Unfortunately, pharmacological options are scarce. The cannabinoid type-2 receptor (CB2R) is neuroprotective in acute experimental stroke by anti-inflammatory mechanisms. However, its role in chronic stroke is still unknown. Methods—: Stroke was induced by permanent middle cerebral artery occlusion in mice; CB2R modulation was assessed by administering the CB2R agonist JWH133 ((6aR,10aR)-3-(1,1-dimethylbutyl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran) or the CB2R antagonist SR144528 ( N -[(1S)- endo -1,3,3-trimethylbicyclo-[2.2.1]-heptan-2-yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide) once daily from day 3 to the end of the experiment or by CB2R genetic deletion. Analysis of immunofluorescence-labeled brain sections, 5-bromo-2´-deoxyuridine (BrdU) staining, fluorescence-activated cell sorter analysis of brain cell suspensions, and behavioral tests were performed. Results—: SR144528 decreased neuroblast migration toward the boundary of the infarct area when compared with vehicle-treated mice 14 days after middle cerebral artery occlusion. Consistently, mice on this pharmacological treatment, like mice with CB2R genetic deletion, displayed a lower number of new neurons (NeuN + /BrdU + cells) in peri-infarct cortex 28 days after stroke when compared with vehicle-treated group, an effect accompanied by a worse sensorimotor performance in behavioral tests. The CB2R agonist did not affect neurogenesis or outcome in vivo, but increased the migration of neural progenitor cells in vitro; the CB2R antagonist alone did not affect in vitro migration. Conclusions—: Our data support that CB2R is fundamental for driving neuroblast migration and suggest that an endocannabinoid tone is required for poststroke neurogenesis by promoting neuroblast migration toward the injured brain tissue, increasing the number of new cortical neurons and, conceivably, enhancing motor functional recovery after stroke.
- 1 August 2014
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 2014 (1094687X) , 4519-4522
Proposal of a KinectTM-based system for gait assessment and rehabilitation in Parkinson's disease
It has been proved that audio and visual cueing can improve the motor performance of Parkinson's disease patients. Specially, gait can benefit from repetitive sessions of exercises using cues. Nevertheless, these effects are not permanent and fade away with time, in that sense, home game systems can be an excellent platform for patients to perform daily exercises, as well as to coach and guide them in a smarter way. Within this work a method to track the walking movement is proposed based on the signals coming from the Kinect sensor of Microsoft. At the same time, different setups have been tested in order to study the feasibility of using this sensor to build a game platform for gait rehabilitation for Parkinson's disease patients.
- 1 August 2014
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 2014 (1094687X) , 4519-4522
Proposal of a KinectTM-based system for gait assessment and rehabilitation in Parkinson's disease
It has been proved that audio and visual cueing can improve the motor performance of Parkinson's disease patients. Specially, gait can benefit from repetitive sessions of exercises using cues. Nevertheless, these effects are not permanent and fade away with time, in that sense, home game systems can be an excellent platform for patients to perform daily exercises, as well as to coach and guide them in a smarter way. Within this work a method to track the walking movement is proposed based on the signals coming from the Kinect sensor of Microsoft. At the same time, different setups have been tested in order to study the feasibility of using this sensor to build a game platform for gait rehabilitation for Parkinson's disease patients.
- 1 May 2014
- Published by Elsevier in Neuroscience
- Vol. 268, 48-65
Characterization of Gcf2/Lrrfip1 in experimental cerebral ischemia and its role as a modulator of Akt, mTOR and β-catenin signaling pathways
- 1 May 2014
- Published by Elsevier in Neuroscience
- Vol. 268, 48-65
Characterization of Gcf2/Lrrfip1 in experimental cerebral ischemia and its role as a modulator of Akt, mTOR and β-catenin signaling pathways
- 1 November 2013
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Guidelines for the economic analysis of a telematic platform for Parkinson's disease monitoring
PERFORM (A sophisticated multi-parametric system FOR the continuous effective assessment and monitoring of motor status in Parkinson's disease and other neurodegenerative diseases) is an European project which aim is to provide doctors with a telematic tool for the remote monitoring of Parkinson's disease (PD) patients at their homes. The technical performance of PERFORM has been addressed in previous publications. The aim of this work is to introduce the best well-known methodologies and indicators used in the health economics field, normally linked to the assessment of drugs or devices, and provide a set of guidelines for the use of these methodologies in the assessment of telehealth systems focused on PD patients. PD will also be introduced in economic terms, i.e. burden and cost of PD. This study will be done with special emphasis in European countries.
- 1 November 2013
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Guidelines for the economic analysis of a telematic platform for Parkinson's disease monitoring
PERFORM (A sophisticated multi-parametric system FOR the continuous effective assessment and monitoring of motor status in Parkinson's disease and other neurodegenerative diseases) is an European project which aim is to provide doctors with a telematic tool for the remote monitoring of Parkinson's disease (PD) patients at their homes. The technical performance of PERFORM has been addressed in previous publications. The aim of this work is to introduce the best well-known methodologies and indicators used in the health economics field, normally linked to the assessment of drugs or devices, and provide a set of guidelines for the use of these methodologies in the assessment of telehealth systems focused on PD patients. PD will also be introduced in economic terms, i.e. burden and cost of PD. This study will be done with special emphasis in European countries.